Latest Business and People News
Updated employee announcements, business news, awards, and recognition in the industry today.
People News
Advarra, a provider of IRB, announces its leadership structure which will include Pat Donnelly as the Chief Executive Officer, Jeff Wendel as President and Chief Operating Officer, Michael J. Woods appointed to the company’s Board of Directors, Randall Hein serving as President of Consulting, and Tony Davis to become Chairman of the Board of Directors.
Clinerion, a supplier of patient data analytics services, has appointed Ian Rentsch as its new CEO.
Clinipace Worldwide, a global full-service CRO, has announced the appointment of Ian Fraser as Senior Vice President of Operations for the European Union and Middle East.
Donald L. Very, Jr.
Julio Casoy
InClinica, a global clinical CRO, announced that Donald L. Very, Jr., Ph.D. has been appointed as Chief Technical Analyst, Devices and Diagnostics, and Julio Casoy as Chief Medical Officer of South America.
Project Data Sphere, an independent, not-for-profit initiative of the CEO Roundtable on Cancer, Inc.’s Life Sciences Consortium, has named Bill Louv as its new president.
Rho, a CRO, announced that Lysa Triantafillou and Matt Healy have joined its team as Director of Quality Assurance and Vice President, Clinical Operations, at its headquarters in Chapel Hill, North Carolina.
Synteract, a full-service CRO, is announcing that Mary Mattes has joined as Senior Vice President, Biometrics and Drug Safety.
uMotif, a patient data platform services provider, has announced the appointment of Steve Powell to the company's board of directors.
Business News
Falcon Consulting Group, Inc., a global research quality and compliance company, has changed its name to Advarra Consulting, Inc.
Recognition
KCR’s patient-centric project #HumanBehindEveryNumber won the iF DESIGN AWARD 2018 in the category of “Professional Concept – Health” which is awarded to a CRO each year.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
